Top Markets
Coin of the day
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDO
Rang in aandelen #42678
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to... Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.
Aandeelprijs
$0.00001
Laatst gesynchroniseerd: 2026-07-30
Marktkapitalisatie
$426.00
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-90.00%
Land
US
Handel Kaleido Biosciences, Inc. (KLDO)

Categorie

Koersgeschiedenis voor Kaleido Biosciences, Inc. (KLDO)
Hoogste slotkoers: $0.00 op 2026-07-01

Laagste slotkoers: $14.23 op 2019-02-01
Koersgeschiedenis van Kaleido Biosciences, Inc. van 2019 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.00%
2025 304.60%
2024 7.34%
2023 -92.98%
2022 -99.97%
2021 -65.59%
2020 50.15%
2019 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR